Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

283 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

2953 (91%)

3247

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

410 (94%)

Reversed:

23 (5%)

435

483 (13%)

16 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Resolved 2021-03-18 2021-04-29 135952
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2020-09-24 2020-11-12 125007
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Actual shortage 2024-12-13 2025-10-30 245615
TEVA-TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Actual shortage 2024-12-19 2025-10-30 246118
TEVA-TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Actual shortage 2024-11-28 2025-10-30 244078
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2023-04-27 2023-06-27 190713
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2024-10-11 2024-11-01 240043
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2020-11-27 2020-12-17 129050
TEVA-TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Resolved 2024-10-11 2024-11-08 240040
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2023-06-20 2023-06-27 195844
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2021-07-22 2021-09-02 142908
TEVA-TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Resolved 2022-12-01 2023-06-09 176818
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2020-01-30 2020-03-19 104902
TEVA-TOPILENE 0.05% CREAM Resolved 2025-09-25 2025-11-20 267862
TEVA-TOPILENE 0.5MG LOTION Resolved 2020-01-24 2020-04-02 104365
TEVA-TOPILENE 0.05% OINTMENT Actual shortage 2024-08-30 2025-09-25 236356
TEVA-TOPILENE 0.05% LOTION Resolved 2023-06-19 2023-07-05 195579
TEVA-TOPILENE 0.05% LOTION Actual shortage 2025-11-20 2026-01-15 272292
TEVA-TOPILENE 0.05% CREAM Resolved 2020-04-10 2020-04-23 111851
TEVA-TOPILENE 0.05% CREAM Resolved 2024-02-08 2024-07-18 218949
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
CEFTRIAXONE SODIUM FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2025-05-28 2025-05-28 258691
CEFTRIAXONE SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2025-05-27 2025-05-27 258359
CEFTRIAXONE SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2021-02-12 2021-02-12 133886
CLOXACILLIN SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14018
CLOXACILLIN SODIUM FOR INJECTION 2G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14021
CLOXACILLIN SODIUM FOR INJECTION 500MG POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14014
COUGH SYRUP WITH CODEINE 30MG 3.3MG 100MG SYRUP SYRUP Reversed 2025-05-28 2025-06-03 258600
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
EPIRUBICIN FOR INJECTION 2MG SOLUTION Discontinued 2020-10-22 2020-10-24 126906
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
EPTIFIBATIDE INJECTION 2MG SOLUTION Discontinued 2017-06-27 2017-06-27 14027
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Discontinued 2017-06-27 2017-06-27 14024
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14033
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344